Healthcare Industry News: intra-aortic balloon pump
News Release - July 9, 2009
MAQUET Cardiovascular Awarded New Contract by NovationWAYNE, N.J., July 9 -- (Healthcare Sales & Marketing Network) -- MAQUET Cardiovascular US Sales LLC announced today that it has signed a new contract with Novation, one of the health care industry's leading group purchasing organizations. Under the terms of this agreement, MAQUET Cardiovascular US Sales LLC will supply VHA Inc., University HealthSystem Consortium (UHC) and Provista customers with its Cardiac Assist counterpulsation system, including Datascope intra-aortic balloon pumps (IABP) and Catheters. Intra-aortic balloon counterpulsation therapy is used in situations when a heart's own cardiac output is insufficient to meet the oxygenation demands of the body, and additional mechanical support is necessary.
"MAQUET has a strong portfolio of cardiovascular patient care products, and we look forward to building on this foundation with Novation in the future," said Raoul Quintero, President and CEO, MAQUET Cardiovascular US Sales LLC. "We are also extremely pleased that Novation recognizes the value of our IABP products, and that the clinical benefits of this innovative technology can now be extended to more of the critically ill patients who need it most."
Improving patient care and quality of life are of utmost importance to MAQUET. As a global leader, MAQUET Cardiovascular offers comprehensive support to perfusionists, interventionalists, cardiac and vascular surgeons and their teams by providing on- as well as off-pump coronary artery bypass surgery solutions in addition to intra-aortic balloon pump therapy solutions.
With a focus on coronary artery bypass graft (CABG) surgery, MAQUET has expertise in extracorporeal circulation and integrates a system of oxygenators, catheters/cannulae, filtration and other advanced heart-lung machine components to optimize cardiopulmonary perfusion outcomes. Additionally, MAQUET offers the market leading VASOVIEW Endoscopic Vessel Harvesting system for saphenous vein graft retrieval, off-pump coronary artery bypass (OPCAB) systems such as the HEARTSTRING III anastomosis device, ACROBAT Stabilizers and Positioners, along with a wide range of HEMASHIELD surgical grafts and fabrics for vascular surgery.
MAQUET Cardiovascular US Sales LLC is a division of MAQUET Medical Systems, part of the publicly listed Swedish group of companies GETINGE AB., a company with over 2.8 billion US dollars in revenues (2008 fiscal year) and 12,800 employees worldwide. In 2008, MAQUET itself generated pro-forma revenues (including the acquisition of Datascope Corp.) of more than 1.4 billion US dollars. The company now has 5,000 employees in 34 international sales and service organizations, as well as a network of more than 200 sales representatives. MAQUET has 170 years of healthcare experience, and is committed to becoming "The Gold Standard" for therapeutic medical equipment across the globe. As a market leader, MAQUET offers innovative medical solutions from three divisions: Surgical Workplaces, Critical Care and Cardiovascular. www.maquet.com
Founded in 1998, Novation is the leading health care contracting services company for more than 2,500 members of VHA Inc. and the University HealthSystem Consortium (UHC), two national health care alliances and nearly 14,000 members of Provista, LLC. Novation offers its customers contract development and management, supply chain data and measurement, and industry knowledge and advocacy. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 500 suppliers. VHA, UHC and Provista members used Novation contracts to purchased nearly $35 billion in 2008. For more information on Novation, visit www.novationco.com.
Source: MAQUET Cardiovascular
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.